Apixaban Price Trend and Forecast 2026-2027

Apixaban prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 1,519/KG in Q1 to USD 1,610/KG by Q2 as firmer factor Xa inhibitor synthesis intermediate costs and recovering anticoagulation therapy and atrial fibrillation stroke prevention formulation procurement reversed the brief Q1 2026 pricing correction. Globally, the average rose from USD 1,070.6/KG in Q1 to USD 1134.8/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 1,143-1,270/KG is expected, with continued firming on Middle East supply disruptions and growing anticoagulation, stroke prevention, and VTE treatment sector demand globally.

Apixaban is a direct oral anticoagulant of the factor Xa inhibitor class, produced by multi-step chemical synthesis from 1-(4-methoxyphenyl)piperazine and 1-cyano-1-methylethylamine building blocks through sequential coupling, cyclisation, and functional group transformations to yield the 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide active pharmaceutical ingredient. The compound selectively and reversibly inhibits free and prothrombinase-bound factor Xa, the convergence point of the intrinsic and extrinsic coagulation pathways, blocking downstream thrombin generation and fibrin clot formation without requiring antithrombin III as a cofactor. The largest pull comes from stroke and systemic embolism prevention in non-valvular atrial fibrillation, where superior stroke reduction with lower intracranial bleeding risk versus vitamin K antagonists has driven rapid adoption globally. Acute treatment and secondary prevention of deep vein thrombosis and pulmonary embolism, extended prophylaxis after hip or knee arthroplasty surgery, and recurrent VTE risk reduction add significant further demand. Growing generic API procurement following patent expiry in multiple markets is expanding the accessible patient and hospital procurement base. Synthesis intermediate costs, anticoagulant prescription volumes, and regional API production capacity all feed into the price.

Apixaban Price Forecast for 2026

The balance of supply and demand for apixaban through H2 2026 leans moderately firm. Factor Xa inhibitor synthesis intermediate costs firmed from Middle East supply disruptions. Anticoagulation therapy for atrial fibrillation stroke prevention and VTE treatment are growing with ageing demographics, atrial fibrillation prevalence, and expanding generic API procurement globally.

The main upside risk is synthesis intermediate cost increases alongside accelerating atrial fibrillation prevalence and VTE management demand. The main downside risk is generic API competition intensification following further patent expiry across markets limiting the global price recovery below forecast.

For the Quarter Ending June 2026

Apixaban Prices Q2 2026:

• United States: USD 1,307/KG
• China: USD 907/KG
• Germany: USD 1,610/KG
• India: USD 1,239/KG

Apixaban Prices in the United States

US Apixaban prices averaged USD 1,307/KG in Q2 2026, up 6.0% from USD 1,233/KG in Q1 2026. Firmer synthesis intermediate costs and recovering atrial fibrillation, DVT, and PE treatment formulation procurement drove consistent buying following the Q1 correction.

Why did the price of Apixaban change in Q2 2026 in the United States?

Firmer factor Xa inhibitor synthesis intermediate costs raised the API production floor. Atrial fibrillation stroke prevention, DVT treatment, and PE anticoagulation formulation procurement lifted buying. Hip and knee arthroplasty VTE prophylaxis demand provided additional support near USD 1,307/KG.

Apixaban Prices in China

Chinese Apixaban prices averaged USD 907/KG in Q2 2026, up 6.0% from USD 856/KG in Q1 2026, the lowest among the tracked markets. Spring anticoagulant and AF stroke prevention export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor as generic API production expanded.

Why did the price of Apixaban change in Q2 2026 in China?

Spring AF stroke prevention and anticoagulant export and domestic procurement lifted buying. Firmer domestic factor Xa synthesis intermediate costs raised the production floor. Growing generic API capacity maintained China as the most affordable source.

Apixaban Prices in Germany

German Apixaban prices averaged USD 1,610/KG in Q2 2026, up 6.0% from USD 1,519/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Recovering AF, DVT, and PE anticoagulation formulation demand maintained consistent buying.

Why did the price of Apixaban change in Q2 2026 in Germany?

Higher factor Xa synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to synthesis substrate chains. Recovering AF stroke prevention and VTE anticoagulation procurement maintained buying near USD 1,610/KG.

Apixaban Prices in India

Indian Apixaban prices averaged USD 1,239/KG in Q2 2026, up 6.0% from USD 1,169/KG in Q1 2026. Growing generic anticoagulant export and AF stroke prevention domestic demand supported buying. Firmer synthesis import costs raised the production floor.

Why did the price of Apixaban change in Q2 2026 in India?

Growing generic anticoagulant and AF stroke prevention export and domestic procurement lifted buying. Firmer factor Xa synthesis import costs raised the production floor. DVT and PE treatment export demand provided additional buying support near USD 1,239/KG.

For the Quarter Ending March 2026

Apixaban Prices Q1 2026:

• United States: USD 1,233/KG
• China: USD 856/KG
• Germany: USD 1,519/KG
• India: USD 1,169/KG

Apixaban Prices in the United States

US Apixaban prices averaged USD 1,233/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-year-end anticoagulant and AF procurement moderation and soft synthesis costs eased the market before the Q2 spring season recovery.

Why did the price of Apixaban change in Q1 2026 in the United States?

Post-year-end AF stroke prevention and anticoagulant procurement moderation reduced buying urgency. Soft factor Xa synthesis intermediate costs eased the production floor. The market eased to USD 1,233/KG before the Q2 spring anticoagulant procurement surge.

Apixaban Prices in China

Chinese prices averaged USD 856/KG in Q1 2026, easing about 1.7% from Q4 2025. Post-Lunar New Year anticoagulant procurement moderation and soft synthesis costs held the market near USD 856/KG.

Why did the price of Apixaban change in Q1 2026 in China?

Post-Lunar New Year anticoagulant and AF stroke prevention procurement moderation reduced urgency. Soft domestic synthesis costs eased the production floor. The market eased to USD 856/KG before the Q2 spring recovery.

Apixaban Prices in Germany

German prices averaged USD 1,519/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-year-end AF and VTE anticoagulant procurement moderation and soft synthesis costs eased the European market near USD 1,519/KG.

Why did the price of Apixaban change in Q1 2026 in Germany?

Post-year-end AF stroke prevention and VTE anticoagulant procurement moderation reduced urgency. Soft synthesis intermediate and energy costs eased the production floor. The market eased to USD 1,519/KG before the Q2 spring anticoagulant procurement recovery.

Apixaban Prices in India

Indian prices averaged USD 1,169/KG in Q1 2026, easing about 2.0% from Q4 2025. Post-holiday anticoagulant procurement moderation and soft synthesis import costs held the market near USD 1,169/KG.

Why did the price of Apixaban change in Q1 2026 in India?

Post-holiday generic anticoagulant and AF procurement moderation reduced urgency. Soft synthesis import costs eased the production floor. The market eased to USD 1,169/KG before the Q2 recovery.

Quarterly Apixaban Price Trends

Global Apixaban prices firmed through Q3 and Q4 2025 on the anticoagulant procurement season, corrected in Q1 2026 on post-year-end moderation, then surged in Q2 2026. The average rose from USD 1,050.0/KG in Q2 2025 to USD 1,071.0/KG in Q3 and USD 1,092.4/KG in Q4, eased to USD 1070.6/KG in Q1 2026, then surged to USD 1134.8/KG in Q2 2026, a net gain of about 8.1% over the window. Factor Xa synthesis intermediate cost cycles and AF stroke prevention and VTE anticoagulant procurement drove the overall pattern.

What was Apixaban Price in 2025?

Apixaban prices firmed modestly through 2025 on consistent AF stroke prevention and VTE treatment demand and expanding generic API procurement. The global average opened near USD 1,030/KG in Q1 2025 and closed at USD 1,092.4/KG in Q4, a full-year gain of about 6.1%. Factor Xa synthesis cost dynamics and anticoagulant procurement drove the quarterly pattern throughout the year.

Apixaban Prices in the United States in 2025

US prices firmed from about USD 1,220/KG in Q1 2025 to USD 1,258/KG by Q4, a gain of 3.1%. Consistent AF stroke prevention, DVT, and PE treatment demand and growing generic procurement maintained the upward trend.

Apixaban Prices in China in 2025

Chinese prices firmed from roughly USD 848/KG in Q1 2025 to USD 873/KG by Q4, a gain of 3.0%. Growing generic API manufacturing and export anticoagulant demand drove the firming through the year.

Apixaban Prices in Germany in 2025

German prices firmed from about USD 1,502/KG in Q1 2025 to USD 1,550/KG by Q4, a gain of 3.2%. Consistent AF stroke prevention, DVT, and VTE prophylaxis demand and firm synthesis costs supported.

Apixaban Prices in India in 2025

Indian prices firmed from roughly USD 1,158/KG in Q1 2025 to USD 1,193/KG by Q4, a gain of 3.0%. Growing generic anticoagulant manufacturing and export demand drove consistent firming.

How We Can Help

Expert Market Research: Your Source for Real-Time Apixaban Price Intelligence

Expert Market Research tracks Apixaban prices continuously across every major producing and consuming region. The team traces causation through factor Xa inhibitor synthesis intermediate economics, anticoagulant and AF stroke prevention procurement cycles, and regional API production capacity. Contact Expert Market Research today for Apixaban pricing data, bespoke market analysis, and strategic procurement advisory.